This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Gw Pharma Limited, Otsuka Pharmaceutical Company, Limited. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wiltshire, GB (2014)
- Salisbury, GB (2015 - 2017)
Company Filing History:
3 out of 66 
2 out of 846 
Years Active: 2014-2017
Title: The Innovations of Etienne De Meijer: Pioneering Cancer Treatment Research
Introduction: Etienne De Meijer, a notable inventor based in Salisbury, GB, is recognized for his contributions to the field of cancer treatment through innovative approaches involving phytocannabinoids. With three patents to his name, De Meijer's work has the potential to revolutionize therapeutic strategies against various types of cancer.
Latest Patents: De Meijer's latest patents underscore his commitment to advancing medical research. One significant invention focuses on "Phytocannabinoids in the Treatment of Cancer," which highlights the use of phytocannabinoids, either isolated or as a botanical drug substance (BDS), specifically targeting diseases such as prostate, breast, and colon cancer. Another important patent, titled "Reference Plant, a Method for Its Production, Extracts Obtained Therefrom and Their Use," presents a reference plant selected to generate an extract that mimics the chemical profile of a comparator plant, allowing researchers to test hypotheses regarding the efficacy of active compounds in medicinal extracts.
Career Highlights: Throughout his career, Etienne De Meijer has worked with esteemed organizations, including GW Pharma Limited and Otsuka Pharmaceutical Company, Limited. These experiences have positioned him at the forefront of research and development in the pharmaceutical industry.
Collaborations: De Meijer's journey has brought him into collaboration with notable professionals, including Daniela Parolaro and Paola Massi. Their collective expertise has contributed to the advancements in research surrounding phytocannabinoids and their applications in medicine.
Conclusion: Etienne De Meijer's innovative work in the realm of cancer treatment using phytocannabinoids lays a foundation for potential breakthroughs in therapeutic interventions. His patents reflect a dedication to harnessing the power of nature to combat cancer, paving the way for future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile